<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2017 (12) TMI 996 - ITAT JAIPUR</title>
    <link>https://www.taxtmi.com/caselaws?id=352727</link>
    <description>The Tribunal allowed the appeal of the assessee, setting aside the disallowances made by the AO and confirmed by the CIT(A). The Tribunal emphasized that the genuineness of the expenses was not doubted and that the MCI regulations did not apply to pharmaceutical companies. The CBDT circular was deemed clarificatory and not the basis for disallowance. The Tribunal&#039;s decision was in line with the jurisdictional High Court&#039;s ruling in a similar case.</description>
    <language>en-us</language>
    <pubDate>Tue, 12 Dec 2017 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 19 Dec 2017 10:25:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=500551" rel="self" type="application/rss+xml"/>
    <item>
      <title>2017 (12) TMI 996 - ITAT JAIPUR</title>
      <link>https://www.taxtmi.com/caselaws?id=352727</link>
      <description>The Tribunal allowed the appeal of the assessee, setting aside the disallowances made by the AO and confirmed by the CIT(A). The Tribunal emphasized that the genuineness of the expenses was not doubted and that the MCI regulations did not apply to pharmaceutical companies. The CBDT circular was deemed clarificatory and not the basis for disallowance. The Tribunal&#039;s decision was in line with the jurisdictional High Court&#039;s ruling in a similar case.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Tue, 12 Dec 2017 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=352727</guid>
    </item>
  </channel>
</rss>